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Abstract
Background: Xylopia frutescens Aubl. (embira, semente-de-embira or embira-vermelha), is used in folk medicine as
antidiarrheal. The essential oil from its leaves (XF-EO) has been found to cause smooth muscle relaxation. Thus, the
aim of this study was to investigate the spasmolytic action by which XF-EO acts on guinea pig ileum.
Methods: The components of the XF-EO were identified by gas chromatography-mass spectrometry. Segments
of guinea pig ileum were suspended in organ bath containing modified Krebs solution at 37 °C, bubbled with
carbogen mixture under a resting tension of 1 g. Isotonic contractions were registered using kymographs and
isometric contractions using force transducer coupled to an amplifier and computer. Fluorescence measurements
were obtained with a microplate reader using Fluo-4.
Results: Forty-three constituents were identified in XF-EO, mostly mono- and sesquiterpenes. XF-EO has been
found to cause relaxation on guinea pig ileum. The essential oil inhibited in a concentration-dependent manner
both CCh- and histamine-induced phasic contractions, being more potent on histamine-induced contractions as
well as antagonized histamine-induced cumulative contractions in a non-competitive antagonism profile. XF-EO
relaxed in a concentration-dependent manner the ileum pre-contracted with KCl and histamine. Since the potency
was smaller in organ pre-contracted with KCl, it was hypothesized that XF-OE would be acting as a K+ channel
positive modulator. In the presence of CsCl (non-selective K+ channel blocker), the relaxant potency of XF-OE was
not altered, indicating a non-participation of these channels. Moreover, XF-EO inhibited CaCl2-induced cumulative
contractions in a depolarizing medium nominally without Ca2+ and relaxed the ileum pre-contracted with S-(-)-Bay
K8644 in a concentration-dependent manner, thus, was confirmed the inhibition of Ca2+ influx through Cav1 by XF-EO.
In cellular experiments, the viability of longitudinal layer myocytes from guinea pig ileum was not altered in the
presence of XF-OE and the Fluo-4-associated fluorescence intensity in these intestinal myocytes stimulated by
histamine was reduced by the essential oil, indicating a [Ca2+]c reduction.
Conclusion: Spasmolytic action mechanism of XF-EO on guinea pig ileum can involve histaminergic receptor
antagonism and Ca2+ influx blockade, which results in [Ca2+]c reduction leading to smooth muscle relaxation.
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Background
Diarrhea is characterized by change in bowel movements
with symptoms of increment in water content, volume
and frequency of stool [1]. It is the second leading cause
of death in children under five years old, and it is respon-
sible for around 760.000 children deaths every year [2].
For this reason, international organizations have encour-
aged studies pertaining to treatment and prevention of
diarrheal diseases using traditional medicinal practices [3].
Xylopia frutecens Aubl. is a tree commonly known in
Brazil as “embira”, “semente-de-embira” and “embira-
vermelha” [4] and belongs to the Annonaceae family. In
folk medicine, its seeds are used to rheumatism and in-
flammation treatment, to improve digestion and as anti-
diarrheal [5–7].
Chemical studies showed that kaurenoic acid, a kaurene
diterpene abundant in the seeds of this species presents
anti-inflammatory [7], analgesic [8], diuretic and vasore-
laxant activities [9]. In addition, pharmacological investi-
gations have demonstrated antiviral [10], antifungal [11],
tripanossomicide [12], antitumor [13] and spasmolytic ac-
tivity [14] for X. frutescens. Despite the common use of
this plant in popular medicine, there is a lack of informa-
tion to support its effect on intestinal smooth muscle.
Hence, the present study aimed to evaluate the spasmo-
lytic activity and possible mechanism of action of the
essential oil from X. frutescens (XF-EO) on guinea pig
ileum, to ascertain ethnopharmacological claims.
Methods
Plant material and essential oil preparation
The plant material of Xylopia frutescens Aubl. was col-
lected in April 2010 in João Pessoa municipality, State
of Paraíba, Brazil. The material was identified by Maria
de Fátima Agra (PhD) of the Centro de Biotecnologia
(CBiotec) of Universidade Federal da Paraíba (UFPB),
and the voucher specimen (Agra 7249) is deposited at
the Prof. Lauro Pires Xavier (JPB) Herbarium/UFPB.
Fresh leaves from Xylopia frutescens were ground and
submitted to hydrodistillation using a Clevenger-type
apparatus (1500 g, 6 h, 40 °C). The oil was dried over
anhydrous sodium sulfate and its percentage content
was calculated on basis of the plant dry weight. The es-
sential oil was used for the spasmolytic activity studies.
Identification of essential oil components
The analysis of the essential oil was carried out on a SHI-
MADZU gas chromatography–mass spectrometry (GC-
MS) instrument under the following conditions: DB-5 ms
(30 m x 0.25 mm d.i., 0.25 μM film thickness), fused-silica
capillary column, programmed temperature of 60-240 °C
(3 °C/min), injector temperature at 220 °C, helium carrier
gas adjusted to a linear velocity of 32 cm/s (measured at
100 °C), splitless injection (2 μL 1:1000 hexane solution),
split flow adjusted to yield a 20:1 ratio, septum sweep
constant at 10 mL/min, EIMS electron energy of 70 eV,
ion source and connections at 200 °C. The quantitative
data for the volatile constituents were obtained by peak-
area normalization using a FOCUS GC/ flame ionization
detector (FID), operated under GC-MS similar conditions
except for the carrier gas, which was nitrogen. The reten-
tion index was calculated for all the volatile constituents
using an n-alkane (C8-C20, Sigma-Aldrich, Brazil) hom-
ologous series.
Individual components were identified by comparison
of both mass spectrum and GC retention data with previ-
ously analyzed authentic compounds stored in our private
library, as well as with the aid of commercial libraries con-
taining mass spectra, and retention indices of volatile
compounds commonly found in essential oils [15, 16].
Chemicals
The following reference chemicals were obtained from the
sources specified: histamine dihydrochloride, carbachol
(CCh) (Merck, EUA), Cremophor EL®, S-(-)-Bay K8644,
cesium chloride (CsCl), EDTA, HEPES, methylthiotetra-
zole (MTT), dimethyl sulfoxide (DMSO), penicillin-
streptomycin (Sigma-Aldrich, Brazil), ethanol PA (Reagen,
Brazil), dulbecco’s modified eagle medium (DMEM),
bovine fetal serum, L-glutamine and trypsin/EDTA solu-
tion (1:250) (Cultilab, Brazil) and Flou-4 NW dye mix
(Invitrogen, EUA).
The following chemicals were used to make the physio-
logical salt solutions: glucose, magnesium sulphate, cal-
cium chloride (Vetec, Brazil), sodium bicarbonate (Fmaia,
Brazil), sodium chloride, potassium chloride (Química
Moderna, Brazil), monosodium phosphate-1-hydrate, so-
dium hydroxide and hydrochloric acid (Nuclear, Brazil)
All chemicals used were of the highest purity grade
available. Stock solutions of all the chemicals were made
in distilled water and the dilutions were made fresh on
the day of the experiment.
Carbogen mixture (95 % O2 and 5 % CO2) was obtained
from White Martins (Brazil).
Animals and organ manipulation
Adult guinea pigs (Cavia porcellus) of both sexes weighing
300–500 g, obtained from Bioterium Prof. Thomas
George of UFPB, were used in this study. Animals had full
access to food (Labina®) and water, were kept in rooms at
21 ± 1 °C and submitted to a 12 h light-dark cycle (lights
on 06 to 18 h). Eighteen hours before experiments, food
was withheld and free access to water was maintained. All
experimental procedures were performed in accordance
with guidelines for the ethical use of animals in applied
etiology studies [17] and approved by UFPB Ethic Com-
mittee on Animal Use (protocol/CEUA no. 0611/13).
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Animals were euthanized by cervical dislocation. An
ileum segment (approximately 15 cm) was removed,
cleaned of adhering fat and connective tissue, and
suspended in organ baths containing modified Krebs
solution [18] at 37 °C and bubbled with carbogen mix-
ture. Solution pH was adjusted to 7.4 with HCl or
NaOH 1 N, as necessary. The resting tension was fixed
at 1 g and the preparation was allowed to stabilization
for 30 min.
To register isotonic contractions, organs were sus-
pended by cotton yarn in organ baths (5 mL) and recorded
on smoked drum through levers coupled to kymographs
(DTF, Brazil). To register isometric contractions, organs
were suspended in steel rods in organ baths (6 mL),
connected to a force transducer (TIM 05), attached to an
amplifier (AECAD04F) and connected to an A/D con-
verter into a PC running AQCAD® software (São Paulo,
Brazil).
Cell culture
The guinea pig ileum was collected and the longitudinal
smooth muscle layer was carefully stripped off. The pieces
removed were placed in warmed physiological solution
and the organ was successively washed with solution with-
out Ca2+ and enriched with penicillin. Afterwards, tissue
samples were transferred to culture bottles and was added
DMEM culture medium supplemented with glutamine
and 10 % bovine fetal serum, then, the bottles were stored
in CO2 incubator [19]. After 24 h, the culture medium
was added to the bottles and 48 h later the bottles were
washed with PBS and the culture medium was replaced
until the bottles become confluent. In this case, the
medium was removed, added trypsin/EDTA (1:2500) for
2 min in incubator and the cells were resuspended in cul-
ture medium and centrifuged (500 × g) for 5 min. The
supernatant was discarded and the pellets formed were
used in the experiments.
Spasmolytic analysis
Effect of XF-EO on carbachol- and histamine-induced phasic
contractions
Two similar concentration-response curves were ob-
tained with CCh (10−6 M) or histamine (10-6 M). Then,
XF-EO effects were determined by pre-incubating the
ileum strips for 15 min with a single concentration of
the essential oil in independent experiments before
adding CCh or histamine. The inhibitory effect exerted
by the essential oil was evaluated based on IC50 analysis,
which is defined as the molar concentration values of an
antagonist which produces 50 % of its maximum inhibi-
tory response, and maximum effect (Emax), assessed
through concentration-response curves in both absence
(control) and presence of XF-EO [20].
Effect of XF-EO on histamine-induced cumulative
contractions
Two similar cumulative concentration-response curves
for histamine (10-9-10-4 M) were induced (control) and
the tissue was exposed to different concentrations of
XF-EO for 15 min, followed by a new histamine cumula-
tive curve. The maximal contraction obtained in the
absence of XF-EO was considered to be 100 % (control)
and all contractions were assessed referring to it. The in-
hibitory effect exerted by the essential oil was evaluated
based on analysis of EC50 values, which is defined as the
molar concentration values of an agonist which pro-
duces 50 % of its maximum effective response, and Emax,
assessed through concentration-response curves in both
absence (control) and presence of XF-EO [21].
Effect of XF-EO on KCl-induced tonic contraction or
histamine-induced tonic contractions in both absence and
presence of non-selective potassium channel blocker
A contraction was induced with KCl (40 mM) or hista-
mine (10−6 M). During the tonic phase, XF-EO was
cumulatively added as an attempt to obtain concentration-
relaxation curves in different preparations. Then, the
histamine-induced tonic contraction was washed out and
CsCl (5 mM), a non-selective K+ channel blocker [22, 23],
was added for 20 min. Then, another tonic contraction
was elicited in the presence of the blocker and the essential
oil was cumulatively added. The relaxant potency of XF-
EO was evaluated by comparing EC50 values in both
absence (control) and presence of CsCl.
Effect of XF-EO on Ca2+ influx
After stabilization period, the modified Krebs solution was
replaced by a depolarizing modified Krebs solution nom-
inally without Ca2+ (KCl, 4 mM was increased to 70 mM
with equimolar exchange for NaCl). After 45 min, two
concentration-response curves to CaCl2 (10
−5 to 10−1 M)
were constructed (control) and the tissue was exposed to
different concentrations of XF-EO for 15 min, followed by
a new concentration-response curve to CaCl2. The max-
imal contraction obtained in the absence of XF-OE was
considered to be 100 % (control) and all contractions
were assessed referring to it. The inhibitory effect
exerted by the essential oil was evaluated based on
analysis of EC50 and Emax values, assessed through con-
centration-response curves in both absence (control) and
presence of XF-EO [24].
In other experiments, the ileum was partially depolar-
ized with KCl (15 mM) for 10 min [25], then, was in-
duced a contraction with S-(-)-Bay K8644 (3 x 10-7 M),
a selective voltage-dependent calcium channel (Cav)
agonist to L-type or CaV1 [26]. During the tonic contrac-
tion, the essential oil was added cumulatively in different
preparations, in order to obtain a relaxation curve. The
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relaxation was expressed as the reversal percentage of
initial contraction elicited by the S-(-)-Bay K8644 and
evaluated by comparing EC50 values in both absence
(control) and presence of the CaV1 agonist.
Effect of XF-EO on myocytes from ileum longitudinal layer
Interference of XF-EO on ileum myocytes viability
Cell viability was determined using the MTT assay [27].
Briefly, ileum myocytes were seeded at the density of
70–80 % confluence per well in 96-well plates for 24 h
incubation and treated with XF-EO. After treatment,
10 μL of MTT (5 mg/mL) was added and the myocytes
were incubated for 6 h at 37 °C in CO2 incubator. The
supernatant was discarded and the water-insoluble dark
blue formazan crystals formed in viable cells were
solubilized in DMSO. The spectrophotometric absorb-
ance was measured at 540 nm using a microplate
reader (FlexStation 3) and the Soft Max Pro software
(Molecular Devices, USA). Triplicate experiments
were performed and the absorbance from the wells of cells
cultured with DMSO was taken as 100 % (control) of via-
bility value.
Effect of XF-EO on cytosolic calcium concentration
of ileum myocytes The pellets were obtained as de-
scribed earlier, cultured in 96-well plates (40.000 cells
per well) and stabilized in incubator for 24 h for cell
adhesion. After this process, the culture medium of
each well was discarded and 50 μL of Fluo-4 (Molecular
Probes/Invitrogen, USA) was added and let rest for
40 min at 37 °C in CO2 incubator [28]. After the fluoro-
phore incorporation, the Fluo-4-associated fluorescence
was quantified in a microplate reader (FlexStation 3)
using the Soft Max Pro software (Molecular Devices,
USA). The excitation of Fluo-4 occurs at 490 nm, and
the light emission at 524 nm. Records were obtained
without interruption for 240 s. The Fluo-4-associated
fluorescence intensity was increased by adding hista-
mine (10−6 M), and later, verapamil (10-6 M) (positive
control), HBSS (negative control) or XF-EO were
added, in different experiments, to assess the action in
modify the [Ca2+]c. Experiments were performed in
triplicate.
Statistical analysis
The values were expressed as mean and standard error
of mean (S.E.M.). Differences between values were statis-
tically compared using Student’s t-test and one-way
ANOVA, followed by Bonferroni’s test when applicable,
and were considered to differ significantly when p < 0.05.
IC50 and EC50 values were calculated with nonlinear re-
gression [29]. All values were analyzed using GraphPad
Prism software version 5.01 (GraphPad Software Inc.,
San Diego CA, USA).
Results
Identification of essential oil components
Forty-three compounds of the XF-OE were identified by
GC-MS, most of them being represented by monoter-
penes (18 %) and sesquiterpenes (67.5 %). The major
components were caryophyllene (23.91 %), γ-cadinene
(12.48 %), β-ocimene (8.19 %), cadin-4-en-10-ol (5.78 %).
δ-cadinene (5.7 %), viridiflorol (4.83 %) and γ-elemene
(4.55 %) (Table 1).
Effect of XF-EO on carbachol- and histamine-induced
phasic contractions
XF-EO (3-729 μg/mL, n = 5) antagonized the phasic
contractions induced by CCh (IC50 = 74.0 ± 8.1 μg/mL)
or histamine (IC50 = 38.1 ± 2.6 μg/mL) (Fig. 1) on
guinea pig ileum in a concentration-dependent man-
ner. The Emax values were 97.2 ± 1.3 and 94.6 ± 3.0 %,
respectively.
Table 1 Chemical composition of the essential oil obtained
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Effect of XF-EO on histamine-induced cumulative
contractions
XF-EO (9-81 μg/mL, n = 5) concentration-dependently
inhibited histamine-induced contractions (Fig. 2).
Histamine cumulative concentration-response was
non-parallelly shifted to the right and its Emax reduced
from 100 % (control) to 81.3 ± 2.9, 67.9 ± 3.5, 50.0 ± 4.7
and 0 %. The EC50 was attenuated from 2.3 ± 0.3 × 10
−7 M
(control) to 3.8 ± 0.9, 7.3 ± 0.1 × 10−7 M and 1.5 ± 0.1 ×
10−6 M (Fig. 2).
Effect of XF-EO on KCl-induced tonic contraction or
histamine-induced tonic contractions in both absence and
presence of non-selective potassium channel blocker
XF-EO (0.3–729 or 0.3–81 μg/mL, n = 5) showed a
concentration-dependent spasmolytic effect on ileum
pre-contracted with KCl (EC50 = 13.9 ± 1.6 μg/mL) or
histamine (EC50 = 7.1 ± 0.6 μg/mL) (Fig. 3a). XF-EO
relaxant effect was partially reversed 2 h after its re-
moval from organ baths in 62.4 ± 4.2 and 77.8 ± 2.5 %,
respectively (data not shown).
XF-EO spasmolytic effect on histamine-induced tonic
contraction did not modify statistically in the presence
of CsCl (EC50 = 7.7 ± 1.2 μg/mL, n = 3) (Fig. 3b).
Effect of XF-EO on Ca2+ influx
XF-EO (9-81 μg/mL, n = 5) concentration-dependently
inhibited Ca2+-induced cumulative contractions in a
depolarizing medium nominally without Ca2+ (Fig. 4a).
CaCl2 cumulative concentration-response curve was
non-parallelly shifted to the right and Emax reduced
from 100 % (control) to 93.2 ± 3.6, 77.7 ± 4.0, 26.3 ±
2.2 and 10.7 ± 2.6 %. The EC50 was attenuated from
0.7 ± 0.1 × 10−3 M (control) to 1.0 ± 0.1, 4.0 ± 0.2 and
9.5 ± 1.3 × 10−3 M (Fig. 5).
XF-EO (0.1–729 μg/mL, n = 5) showed a concentration-
dependent spasmolytic effect on ileum pre-contracted
with S-(-)-Bay K8644, a selective CaV1 agonist (Fig. 4b).
XF-EO was 5 fold more potent in relaxing the ileum pre-
contracted with KCl (EC50 = 13.9 ± 1.6 μg/mL) than with
S-(-)-Bay K8644 (EC50 = 74.5 ± 8.2 μg/mL).
Fig. 1 Effect of XF-EO on phasic contractions induced by CCh (a) or histamine (b) on guinea pig ileum (n = 5). Columns and vertical bars
represent mean and S.E.M, respectively. One-way ANOVA followed by Bonferroni’s test, *p < 0.05, ***p < 0.001 (control vs. XF-EO)
Fig. 2 Cumulative concentration-response curves to histamine in
both absence (●) and presence of XF-EO: 3 (○), 9 (■), 27 (□) and
81 μg/mL (▲) on guinea pig ileum (n = 5). Symbols and vertical bars
represent mean and S.E.M, respectively. One-way ANOVA followed
by Bonferroni’s test, **p < 0.01, ***p < 0.001 (Control vs. XF-EO)
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Effect of XF-EO on myocytes from ileum longitudinal
layer
Interference of XF-EO in the viability of ileum myocytes
XF-EO (81 μg/mL, n = 3) did not induced cellular death
on ileum myocytes during 2 h of exposure (Fig. 5).
Effect of XF-EO on cytosolic calcium concentration of
ileum myocytes
Histamine (10−6 M) induced an increase on Fluo-4-
associated fluorescence intensity, remaining stable
throughout the stimulation period (220 s) (Figs. 6a and 7).
After the stimulation with histamine, at 110 s, XF-EO
(81 μg/mL) addition induced a reduction on Fluo-4-
associated fluorescence intensity of cells, sustaining this
reduction (97.0 ± 3.0 %, n = 3) throughout the period of
exposure to the essential oil (Figs. 6b and 7). In the
same way, verapamil (10−6 M), a CaV1 blocker, reduced
the [Ca2+]c in the initial 10 s, staying reduced (65.5 ±
4.1 %, n = 3) throughout the observation period, show-
ing a significant Fluo-4-associated fluorescence inten-
sity decrease (Figs. 6c and 7). The Fluo-4-associated
fluorescence decrease showed during the initial 20 s of
exposure of the cells to the drugs is caused for the
presence of HBSS, as can be demonstrated by a biphasi-
cal elevation of the Fluo-4-associated fluorescence in-
tensity after histamine addition, falling slightly and
remaining stable throughout the observation period
(Figs. 6d and 7).
Discussion
This study demonstrated for the first time that the es-
sential oil from leaves of Xylopia frutescens Aubl. (XF-
EO) shows spasmolytic action on guinea pig ileum.
Moreover, the most significant finding concerns the
Fig. 3 Effect of XF-EO on tonic contractions induced by KCl (40 mM) (∇) or histamine (10−6 M) in both absence (▼) (a) and presence (◊) of CsCl
(5 mM) (b) on guinea pig ileum (n = 3–5). Symbols and vertical bars represent mean and S.E.M., respectively
Fig. 4 Effect of XF-EO on cumulative curves to CaCl2 in absence (●) or presence of 3 (○), 9 (■), 27 (□) and 81 μg/mL (▲) (a) or KCl (40 mM) (∇) or
S-(-)-Bay K8644 (3 x 10−7 M) (♦) tonic contraction (b) on guinea pig ileum (n = 5). Symbols and vertical bars represent mean and S.E.M, respectively.
One-way ANOVA followed by Bonferroni’s test, ***p < 0.001 (Control vs. XF-EO)
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characterization of relaxant action mechanism, which in-
cludes histaminergic receptor antagonism and possible
blockade of Cav1 which reduces cytosolic Ca
2+ concentra-
tion ([Ca2+]c) leading to smooth muscle relaxation.
Pharmacologic diarrhea therapy include antimotility,
spasmolytic, antisecretory, adsorbents, probiotics, anti-
infective and miscellaneous agents like α2-adrenergic re-
ceptor antagonist, Ca2+ channel blockers and calmodulin
inhibitors [30, 31]. Spasmolytic agents can act by block-
ing specific receptors present in smooth muscles, such
as muscarinic cholinergic or histamine receptors, in a
non-specific way, reducing the contractile response from
several patterns of stimuli [32].
In the investigation of this study, we detected the pres-
ence of spathulenol (1.37 %), considered a marker of
essential oils obtained from Xylopia genus [33] on the
XF-EO. In addition, this essential oil presented a higher
percentage of mono- and sesquiterpenes (Table 1). In
the pharmacological approach, we found that XF-EO
inhibited both CCh- and histamine-induced contractions
in a concentration-dependent manner, being more po-
tent in antagonized the histamine-induced contractions
(Fig. 1). These data indicate that the essential oil might
be acting as a direct antagonist of histamine receptors to
promote its spasmolytic effect.
Thus, we investigated the role of histamine receptors
using cumulative concentration-response curves to this
agonist. XF-EO showed a noncompetitive pharmaco-
logic profile, shifting the histamine cumulative curve
nonparallelly to the right with Emax reduction (Fig. 2),
so the competitive antagonism on histaminergic recep-
tors was refuted. Inhibition of histamine contractile
response in XF-EO presence have no shown a limiting
value, suggesting a noncompetitive pseudo-irreversible
antagonism of H1 receptors. In this particular kind of
antagonism, the drug dissociation rate occurs slowly,
presenting a prolonged action [34].
Smooth muscle presents a biphasic contraction attrib-
uted to a dual source of Ca2+ [35, 36]. Particularly, on
ileum contraction, the first phase exhibits a fast and
transient contraction (phasic component) followed by a
long-lasting second phase characterized by the main-
tained contraction (tonic component) [37, 38]. The
removal of extracellular Ca2+ prevents contractile re-
sponses induced by depolarizing agents (electromechan-
ical coupling), such as KCl, or by agonists of mixed
coupling (pharmacomechanical and electromechanical),
such as histamine, in few seconds, suggesting that the
intracellular Ca2+ do not contribute significantly to the
tension level [39].
Since the mechanisms involved in tonic contraction
maintenance are different from the phasic contraction
on guinea-pig ileum [35], we decided to investigate if the
essential oil promotes ileum relaxation when pre-
contracted with KCl or histamine. XF-EO relaxed this
organ pre-contracted with both contractile agents in a
concentration-dependent manner, being 2 folds more
potent in relaxing the ileum pre-contracted with hista-
mine (Fig. 3a). Partial reverse effect observed can be
justified by a noncompetitive pseudo-irreversible antag-
onism promoted by the essential oil.
Considering that K+ channel openers reduce contract-
ile response evoked by low K+ concentration and pre-
sents potency decreased at high K+ concentration [40],
another relevant hypothesis is that the essential oil can
acts as a K+ channel positive modulator. Therefore, in
order to verify this hypothesis, XF-EO relaxant effect
was assayed in the presence of CsCl, a non-selective K+
channel blocker. The presence of CsCl did not alter the
essential oil spasmolytic potency (Fig. 3b), suggesting
that these channels are not involved in XF-EO action
mechanism.
Ileal contractile responses are highly dependent on an
increase in free cytoplasmic Ca2+. The [Ca2+]c increase is
due to either influx via CaV or release from intracellular
stores [41]. To test if the essential oil is blocking Ca2+
influx through CaV to promote the spasmolytic action,
CaCl2 cumulative contractions were induced in a de-
polarizing medium nominally without Ca2+. This proto-
col is based on the fact that contraction will be obtained
almost exclusively by Ca2+ from extracellular medium,
since depolarization promoted by elevated extracellular
K+ concentrations leads to CaV opening [42]. XF-EO
Fig. 5 Effect of XF-EO (81 μg/mL) on cell viability of myocytes from
the longitudinal layer of guinea pig ileum (n = 3). Columns and vertical
bars represent mean and S.E.M, respectively. Student’s t-test, *p < 0.05
(Control vs. XF-EO)
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inhibited CaCl2-induced contractions, shifting the curves
to the right and reducing Emax (Fig. 4a), reinforcing the
hypothesis of Ca2+ influx blockade.
CaV are composed by 4 subunits (2 α, 1 β and 1 γ) where
α1 forms the pore that leads to Ca2+ influx [43, 44] and
are subdivided as CaV1.1, CaV1.2, CaV1.3 and CaV1.4,
sensitive to dihydropyridine and high voltage [45]. In
smooth muscle, CaV1 are the main responsible to Ca
2+
influx. Thus, the next step was to confirm and identify the
CaV subtype involved on XF-EO spasmolytic action.
Therefore, tonic contractions were obtained with S-
(-)-Bay K8644, a specific dihydropyridine derivative agon-
ist for CaV1 that binds directly with α1 subunit to open
these channels, but not by depolarization [46]. XF-EO
relaxed the ileum pre-contracted with KCl than S-(-)-Bay
K8644 (Fig. 4b) suggesting the inhibition of Ca2+ influx
through CaV1. Meanwhile, the essential oil was more
potent in relaxing the ileum pre-contracted with KCl than
S-(-)-Bay K8644 (Fig. 4b), suggesting that the Ca2+ influx
blockade through CaV1 is implicated in the essential oil
action mechanism, however other mechanisms seems to
be involved in these spasmolytic action, as the inhibited of
Ca2+ release from intracellular stores [47].
The [Ca2+]c decrease is required to promote relaxation
on smooth muscle [48, 49]. Nowadays, techniques that
use fluorescent indicators allow us to measure the cyto-
solic Ca2+ concentration in several models of smooth
muscles [50]. Heretofore, the XF-EO spasmolytic action
mechanism theoretically reduces [Ca2+]c availability pos-
sible due to CaV1 blockade, but no evidence of this has
been shown. Thus, we aimed to provide evidence of [Ca2
+]c reduction by the essential oil in myocytes isolated
from ileum longitudinal layer and, so, better characterize
its action mechanism. Initially, cell viability was evalu-
ated using the XF-EO maximal concentration used in
functional level. In 2 h of XF-EO exposure to the cells
was not observed cell death (Fig. 5), this data shows that
spasmolytic action is not due to cell death. This way,
Fig. 6 Representative records of control (a), XF-EO (81 μg/mL) (b), verapamil (10-6 M) (c) and HBSS (d) effects under the sign of calcium in myocytes
from the longitudinal layer of guinea pig ileum stimulates with histamine (10−6 M) and loaded with Fluo-4
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Fluo-4, a fluorescent indicator of Ca2+, was added to the
preparations containing ileum myocytes and the resultant
Fluo-4-associated fluorescence was quantified in XF-EO
presence. The essential oil reduced the great Fluo-4-
associated fluorescence emitted in histamine presence,
which indicates [Ca2+]c reduction of 97 % approximately
(Figs. 6 and 7). This reduction is consistent with what was
observed in functional level, where maximum relaxation
(100 %) was obtained in the 81 μg/mL concentration
(Fig. 3a). These results in cellular experiments support our
findings in functional level and evidence that XF-EO
reduce [Ca2+]c to play its spasmolytic role.
Conclusion
In conclusion, the spasmolytic action of the essential oil
from Xylopia frutescens Aubl. on guinea pig ileum involves
the histaminergic receptor antagonism and possible CaV1
blockade. In addition, it is now established that, in cellular
experiments, XF-EO decrease [Ca2+]c to promote the
spasmolytic action observed in tissue experiments. Further
complementary studies on this essential oil in vivo proto-
col are needed to pursue the search for a potential anti-
diarrheal agent.
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